相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses
Long Chi Nguyen et al.
SCIENCE ADVANCES (2022)
An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study
Sourav Das et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Epigallocatechin gallate and theaflavin gallate interaction inSARS-CoV-2 spike-protein central channel with reference to the hydroxychloroquine interaction: Bioinformatics and molecular docking study
Smarajit Maiti et al.
DRUG DEVELOPMENT RESEARCH (2021)
Identification of phytochemicals as potential therapeutic agents that binds to Nsp15 protein target of coronavirus (SARS-CoV-2) that are capable of inhibiting virus replication
Suresh Kumar et al.
PHYTOMEDICINE (2021)
Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
Jingwei Bian et al.
ACTA PHARMACEUTICA SINICA B (2021)
Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches
Vinit Raj et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)
Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro
Hongbo Liu et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
Computational study of pomegranate peel extract polyphenols as potential inhibitors of SARS-CoV-2 virus internalization
Relja Surucic et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2021)
Lycorine, a non-nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections
Young-Hee Jin et al.
PHYTOMEDICINE (2021)
Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection
Jia-Tsrong Jan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Cannabis compounds exhibit anti-inflammatory activity in vitro in COVID-19-related inflammation in lung epithelial cells and pro-inflammatory activity in macrophages
Seegehalli M. Anil et al.
SCIENTIFIC REPORTS (2021)
Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of Mechanisms
Mohsin Ali Khan et al.
JOURNAL OF INFLAMMATION RESEARCH (2021)
EGCG, a Green Tea Catechin, as a Potential Therapeutic Agent for Symptomatic and Asymptomatic SARS-CoV-2 Infection
Mukesh Chourasia et al.
MOLECULES (2021)
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
I. O. Rosas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases
Zinuo Chen et al.
CELL AND BIOSCIENCE (2021)
Corilagin inhibits SARS-CoV-2 replication by targeting viral RNA-dependent RNA polymerase
Quanjie Li et al.
ACTA PHARMACEUTICA SINICA B (2021)
Anti-SARS-CoV-2 Activity of Andrographis paniculata Extract and Its Major Component Andrographolide in Human Lung Epithelial Cells and Cytotoxicity Evaluation in Major Organ Cell Representatives
Khanit Sa-ngiamsuntorn et al.
JOURNAL OF NATURAL PRODUCTS (2021)
Efficacy of Phytochemicals Derived from Avicennia officinalis for the Management of COVID-19: A Combined In Silico and Biochemical Study
Shafi Mahmud et al.
MOLECULES (2021)
Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding
Li Jun Yang et al.
PHYTOMEDICINE (2021)
Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease
Lukas van de Sand et al.
VIRUSES-BASEL (2021)
Emergent Drug and Nutrition Interactions in COVID-19: A Comprehensive Narrative Review
Duygu Agagunduz et al.
NUTRIENTS (2021)
Structure insights of SARS-CoV-2 open state envelope protein and inhibiting through active phytochemical of ayurvedic medicinal plants from Withania somnifera
Raed Abdullah Alharbi
SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2021)
The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets
Thomas P. Peacock et al.
NATURE MICROBIOLOGY (2021)
Phytochemical Moieties From Indian Traditional Medicine for Targeting Dual Hotspots on SARS-CoV-2 Spike Protein: An Integrative in-silico Approach
V Umashankar et al.
FRONTIERS IN MEDICINE (2021)
Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment
Hirofumi Ohashi et al.
ISCIENCE (2021)
Pomegranate peel extract polyphenols attenuate the SARS-CoV-2 S-glycoprotein binding ability to ACE2 Receptor: In silico and in vitro studies
Relja Surucic et al.
BIOORGANIC CHEMISTRY (2021)
Targeting the intestinal TMPRSS2 protease to prevent SARS-CoV-2 entry into enterocytes-prospects and challenges
Ismail Sami Mahmoud et al.
MOLECULAR BIOLOGY REPORTS (2021)
In Silico Evaluation of Iranian Medicinal Plant Phytoconstituents as Inhibitors against Main Protease and the Receptor-Binding Domain of SARS-CoV-2
Seyyed Sasan Mousavi et al.
MOLECULES (2021)
Traditional Herbal Medicines, Bioactive Metabolites, and Plant Products Against COVID-19: Update on Clinical Trials and Mechanism of Actions
Safaet Alam et al.
FRONTIERS IN PHARMACOLOGY (2021)
SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns
Natalia Redondo et al.
FRONTIERS IN IMMUNOLOGY (2021)
dIdentification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen
Maria Kuzikov et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
A pharmacology-based comprehensive review on medicinal plants and phytoactive constituents possibly effective in the management of COVID-19
Atefeh Jalali et al.
PHYTOTHERAPY RESEARCH (2021)
Coronavirus biology and replication: implications for SARS-CoV-2
Philip V'kovski et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
Yushun Wan et al.
JOURNAL OF VIROLOGY (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
Canrong Wu et al.
ACTA PHARMACEUTICA SINICA B (2020)
The spike glycoprotein of the new coronavirus 2019-nCoV contains a furinlike cleavage site absent in CoV of the same clade
B. Coutard et al.
ANTIVIRAL RESEARCH (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
SARS-CoV-2, an evolutionary perspective of interaction with human ACE2 reveals undiscovered amino acids necessary for complex stability
Vinicio Armijos-Jaramillo et al.
EVOLUTIONARY APPLICATIONS (2020)
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
Jianjun Gao et al.
BIOSCIENCE TRENDS (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
Markus Hoffmann et al.
MOLECULAR CELL (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug discovery from medicinal plants
Muhammad Tahir ul Qamar et al.
JOURNAL OF PHARMACEUTICAL ANALYSIS (2020)
Investigation into SARS-CoV-2 Resistance of Compounds in Garlic Essential Oil
Bui Thi Phuong Thuy et al.
ACS OMEGA (2020)
Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients
Hai-xia Su et al.
ACTA PHARMACOLOGICA SINICA (2020)
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
Ka-Tim Choy et al.
ANTIVIRAL RESEARCH (2020)
Tackling SARS-CoV-2: proposed targets and repurposed drugs
Siddhi Joshi et al.
FUTURE MEDICINAL CHEMISTRY (2020)
Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: Anin silicoAnalysis
Rajaiah Alexpandi et al.
FRONTIERS IN MICROBIOLOGY (2020)
Ribavirin therapy for severe COVID-19: a retrospective cohort study
Song Tong et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Anti-SARS-CoV-2 Potential of Artemisinins In Vitro
Ruiyuan Cao et al.
ACS INFECTIOUS DISEASES (2020)
Geranium and Lemon Essential Oils and Their Active Compounds Downregulate Angiotensin-Converting Enzyme 2 (ACE2), a SARS-CoV-2 Spike Receptor-Binding Domain, in Epithelial Cells
K. J. Senthil Kumar et al.
PLANTS-BASEL (2020)
Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells
Gennadi Glinsky
BIOMEDICINES (2020)
TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells
Dorothea Bestle et al.
LIFE SCIENCE ALLIANCE (2020)
Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach
Ahmad Abu Turab Naqvi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Roles of flavonoids against coronavirus infection
Maria Russo et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2020)
In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19
Seshu Vardhan et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2020)
Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway
Qinhai Ma et al.
PHYTOMEDICINE (2020)
SARS-CoV-2/COVID-19: a primer for cardiologists
A. A. F. de Vries
NETHERLANDS HEART JOURNAL (2020)
Protective potential of expectorants against COVID-19
Zohreh Esam
MEDICAL HYPOTHESES (2020)
Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2
Muchtaridi Muchtaridi et al.
MOLECULES (2020)
Potential Anti-SARS-CoV-2 Therapeutics That Target the Post-Entry Stages of the Viral Life Cycle: A Comprehensive Review
Rami A. Al-Horani et al.
VIRUSES-BASEL (2020)
Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2
Anamika Basu et al.
SCIENTIFIC REPORTS (2020)
Antiviral activity of digoxin and ouabain against SARS-CoV-2 infection and its implication for COVID-19
Junhyung Cho et al.
SCIENTIFIC REPORTS (2020)
Computational evaluation of major components from plant essential oils as potent inhibitors of SARS-CoV-2 spike protein
Seema A. Kulkarni et al.
JOURNAL OF MOLECULAR STRUCTURE (2020)
High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents
Phongthon Kanjanasirirat et al.
SCIENTIFIC REPORTS (2020)
Geranii Herba as a Potential Inhibitor of SARS-CoV-2 Main 3CLpro, Spike RBD, and Regulation of Unfolded Protein Response: An In Silico Approach
Selvaraj Arokiyaraj et al.
ANTIBIOTICS-BASEL (2020)
Molecular docking between human TMPRSS2 and SARS-CoV-2 spike protein: conformation and intermolecular interactions
Mushtaq Hussain et al.
AIMS MICROBIOLOGY (2020)
Molecular basis for drug repurposing to study the interface of the S protein in SARS-CoV-2 and human ACE2 through docking, characterization, and molecular dynamics for natural drug candidates
Meshari Alazmi et al.
JOURNAL OF MOLECULAR MODELING (2020)
Flavonoid glycosides and their putative human metabolites as potential inhibitors of the SARS-CoV-2 main protease (Mpro) and RNA-dependent RNA polymerase (RdRp)
Felipe Moura A. da Silva et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2020)
Natural RNA dependent RNA polymerase inhibitors: Molecular docking studies of some biologically active alkaloids of Argemone mexicana
K. B. Pandeya et al.
MEDICAL HYPOTHESES (2020)
SARS-CoV-2 RNA Dependent RNA polymerase (RdRp) - A drug repurposing study
Jamshaid Ahmad et al.
HELIYON (2020)
Potential Role of Peptide-Based Antiviral Therapy Against SARS-CoV-2 Infection
Biplab K. Maiti
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro
Seri Jo et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors
Robert N. Kirchdoerfer et al.
NATURE COMMUNICATIONS (2019)
Nucleocapsid proteins: roles beyond viral RNA packaging
Binbin Ding et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2016)
Epigallocatechin-3-gallate (EGCG) Suppresses the Trafficking of Lymphocytes to Epidermal Melanocytes via Inhibition of JAK2: Its Implication for Vitiligo Treatment
Weixuan Ning et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
Citral alleviates an accelerated and severe lupus nephritis model by inhibiting the activation signal of NLRP3 inflammasome and enhancing Nrf2 activation
Shuk-Man Ka et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein
Jean Kaoru Millet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Withaferin A inhibits pro-inflammatory cytokine-induced damage to islets in culture and following transplantation
J. A. SoRelle et al.
DIABETOLOGIA (2013)
Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
Ji-Young Park et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Lemongrass and citral effect on cytokines production by murine macrophages
Tatiana Fernanda Bachiega et al.
JOURNAL OF ETHNOPHARMACOLOGY (2011)
SF1 and SF2 helicases: family matters
Margaret E. Fairman-Williams et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2010)
Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus
Chih-Chun Wen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells
D Kempuraj et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
I Hamming et al.
JOURNAL OF PATHOLOGY (2004)
The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor
HT Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
分享论文
